EAEkaterina Vladimirovna Anufrieva

Ekaterina Vladimirovna Anufrieva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina Vladimirovna Anufrieva has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Population Immunity to Enteric Hepatitis Viruses in the Population of Belgrade

    by Anna Yurievna Popova, Alesia Yuryevna Olkhovskaya, Luka Dragačević, Yulia Vladimirovna Ostankova, Svetlana Alexandrovna Egorova, Alexander Nikolaevich Schemelev, Darya Tsibulskaya, Ekaterina Vladimirovna Anufrieva, Anastasiya Romanovna Ivanova, Irina Victorovna Drozd, et al.

    Background: Hepatitis A (HA) and E (HE) represent a significant global health burden. Despite the development of effective vaccines against hepatitis A virus (HAV) and hepatitis E virus (HEV), outbreaks of acute HA and HE continue to occur worldwide. This study aimed to assess the seroprevalence of anti-HAV and anti-HEV IgG antibodies (Abs) in the population of Belgrade and to analyze their association with socio-demographic and clinical factors. Materials and Methods: A cross-sectional study was conducted on a sample of 2533 healthy volunteers in Serbia in May 2024. Participation was voluntary and web-based, leading to an overrepresentation of women and middle-aged adults, while children were underrepresented. Due to this non-probabilistic recruitment, the absolute seroprevalence estimates have limited generalizability to the entire population of Belgrade. Serum samples were tested for anti-HAV and anti-HEV IgG using commercial ELISA kits. The anti-HEV estimate is based on a single ELISA without confirmatory testing and should be interpreted with this limitation in mind. Statistical analysis included confidence interval estimation, chi-square tests, and Spearman’s correlation. Results: Overall seroprevalence was 20.5% (95% CI: 18.9–22.1) for anti-HAV and 22.6% (95% CI: 21.0–24.3) for anti-HEV. A strong, non-linear increase in anti-HAV seroprevalence with age was observed, rising sharply from 2.8% in the 18–29 group to 78.3% in those aged 70+. Anti-HEV seroprevalence also featured a significant positive correlation with age (rs = 0.99, p < 0.0001), increasing from 4.2% in children (1–17 years) to 49.2% in the 70+ group. Men had significantly higher anti-HAV seroprevalence than women (23.1% vs. 19.3%, p = 0.029). Individuals with a history of surgical interventions or blood transfusions had significantly higher odds of being anti-HEV positive (OR = 1.41, p = 0.0005). Vaccination coverage against HAV was low (1.8%), and Abs were detected in only 28.6% of vaccinated individuals. Conclusions: This study suggests high HEV seroprevalence and an age-polarized HAV seroprevalence in Serbia, indicating a significant shift in the epidemiological landscape while acknowledging the sampling and assay limitations stated above. The findings underscore a growing population susceptible to HAV and highlight the need for reinforced vaccination strategies, improved diagnostics, and targeted public health interventions.

  • Open Access

    Identification and multiparametric ranking of candidate genes involved in hepatitis C virus entry and host immune response using bioinformatics methods

    by Ekaterina V. Anufrieva, Yulia V. Ostankova, Vladimir S. Davydenko, Alexander N. Shchemelev, Areg A. Totolian, Щемелев Александр Николаевич

    Introduction. Hepatitis C virus (HCV) remains a significant public health concern. The application of existing antiviral agents is restricted by their high cost and the development of viral resistance, while vaccine development is impeded by the considerable genetic variability of HCV. The outcome of infection is largely determined by the host's genetic factors, which influence both the viral entry into the cell and the effectiveness of antiviral immunity. Identification of genetic determinants involved in these processes is essential for understanding pathogenesis and discovering novel therapeutic targets. Objective. A comprehensive assessment of the potential involvement of candidate genes and their products in the pathogenesis of HCV infection at the stages of viral entry into the cell and the formation of the host immune response, based on an integrative analysis of gene expression, subcellular localization of their products, and participation in molecular pathways and biological processes. Materials and methods. In this study, a comparative analysis of 35 most promising candidate genes was performed against five background genes (CD81, CLDN1, LDLR, OCLN, SCARB1) encoding key HCV entry receptors. To analyze biological mechanisms associated with priority genes, the FUMA GWAS platform was used in the functional mapping mode GENE2FUNC (https://fuma.ctglab.nl/gene2func). Evaluation of candidate genes included analysis of their expression profiles, subcellular localization of protein products, as well as involvement in molecular pathways and biological processes. A ranking scoring system was developed, based on point-based ranking, which allowed determining the significance of each candidate gene in the context of its potential involvement in HCV pathogenesis. The system includes sequential assessment by several independent criteria, the results of which are summed into a single score. The degree of association between candidate genes and background genes was assessed using the phi-correlation coefficient (φ) across categories of subcellular localization, molecular pathways, and biological processes. Results. Application of the developed scoring system identified 25 significant candidate genes. The highest scores were obtained for genes involved in intercellular junction organization (CLDN3, CLDN5, CLDN12, ESAM, F11R, TJP1, TJP2) and lipid metabolism regulation (APOE, LDLRAP1). Enrichment of several candidate genes in immunological processes was revealed. A stable association of C3 and CD19 genes with immune process regulation was established, which is of particular interest in light of HCV's ability to infect mononuclear cells. The APOE, ITGB1, F11R genes demonstrated involvement in inflammatory and defense responses, while IFITM1 was associated with response to cytokine stimulation. Conclusion. A group of candidate genes potentially influencing HCV infection pathogenesis both at the viral entry stage and through immune modulation was identified. The obtained data expand understanding of virus-host interactions and justify the need for experimental validation of the identified genes as potential biomarkers and therapeutic targets.

  • Open Access

    HIV and Parenteral Viral Hepatitis in the Co-Morbidity Structure of Patients with Post-COVID Syndrome

    by Yu. V. Ostankova, A. N. Shchemelev, E. N. Serikova, E. V. Anufrieva, E. V. Zagal’sKaya, A. A. Knizhnikova, A. O. Norka, V. V. Rassokhin, N. A. Belyakov, Аreg A. Totolian

    The aim of our study was to assess the prevalence of HIV and blood-borne viral hepatitis markers among individuals with post-COVID syndrome. Materials and methods . The study material consisted of blood plasma samples from 129 patients diagnosed with long COVID. The samples were tested for serological (ELISA with commercial kits, in case of Ag/Ab-HIV detection – Western blot) and molecular (PCR assay) markers. Results and discussion . Evaluation of overall marker prevalence revealed complex relationships between HIV infection, viral hepatitis, and the development of post-COVID syndrome in the cohort. Our data demonstrate that among HIV-positive patients receiving antiretroviral therapy – who constituted 6.97 % of the study cohort – mild forms of COVID-19 were predominant (55.56 % of cases). This finding aligns with the current understanding of the modulating effect that immunosuppression has on the cytokine storm in case of COVID-19. Furthermore, analysis of the results revealed a higher detection rate of HCV RNA (1.55 %) compared to the general population. This observation warrants further investigation into the potential role of HCV in the development of long COVID, particularly in light of data suggesting prolonged SARS-CoV-2 viremia in this patient category. Conversely, the low prevalence of HB markers (7.75 % anti-HBcore antibodies with no HBsAg-positive cases) did not confirm their association with post-COVID syndrome in our sample, despite literature suggesting increased long COVID risk against chronic hepatitis B. Assessment of blood-borne infection prevalence among COVID-19 survivors may be valuable for early identification of high-risk patients developing post-COVID syndrome. The results emphasize the need for larger-scale studies to clarify pathogenic mechanisms of interaction between chronic viral infections and SARS-CoV-2, as well as to develop personalized monitoring and management approaches for high-risk long COVID patients.

  • Open Access

    Bloodborne infections in dental practice: prevalence of markers and phylogenetic analysis of circulating strains

    by Yulia V. Ostankova, Elena N. Serikova, Alexandr N. Schemelev, Ekaterina V. Anufrieva, Elena B. Zueva, Olga S. Kreidik, Marina B. Kusevitskaya, Leonid Ya. Kusevitskiy, Areg A. Totolian

    Introduction. Human immunodeficiency virus (HIV) and hepatitis B (HBV) and C (HCV) viruses remain among the most dangerous bloodborne pathogens, posing a significant global public health threat. The aim of our work was to assess the prevalence of HIV, HBV, and HCV markers among dental patients and provide a molecular genetic characterization of the identified pathogens. Materials and methods. We analyzed 497 plasma samples from individuals who sought dental care in St. Petersburg for serological and molecular markers of target infections. Viral genome fragments were sequenced and analyzed when molecular markers were detected. Results. Anti-HCV were detected in 3.8% (19/497) of participants, with HCV RNA in 1% (5/497). HIV Ag/Ab was found in 1.2% (6/497), with two cases (0.4%, 2/497) confirmed by immunoblot; no HIV RNA was detected. HBsAg prevalence was 2.4% (12/497), with anti-HBs in 32.0% (159/497) and anti-HBc in 25.6% (127/497) of participants. Significant age-related trends were observed: anti-HBs predominated in younger groups while anti-HBc was more frequent in older individuals. HBV DNA was detected in 3.8% (19/497) of cases, including 1.8% (9/497) HBsAg-negative infections. Predominant in the Russian Federation viral genotypes were identified (HCV: 1b, 2a, 3a; HBV: D1, D2, D3). One HCV isolate carried mutations associated with resistance to dasabuvir, sofosbuvir, and voxilaprevir. Multiple HBV isolates harbored concurrent mutations causing diagnostic escape (HBsAg-negative variants), reduced vaccine efficacy, viral reactivation, and disease progression. Conclusions. The study reveals high viral hepatitis prevalence among dental patients. Detection of drug-resistant HCV variants and immune-evading HBV strains underscores the need for enhanced molecular surveillance, improved diagnostic protocols, and strengthened infection control measures.


  • Open Access

    Effects of CCL2 chemokine missense mutations on CCR5 receptor affinity: a computational study in the context of HIV infection regulator discovery

    by V. S. Davydenko, Alexandr N. Schemelev, Y. V. Ostankova, E. V. Anufrieva, A. A. Totolian

    Introduction. HIV entry into host cells requires CD4 receptors and CCR5 co-receptors. Natural CCR5 ligands can inhibit HIV through steric blocking and receptor internalization. Although CCL2 is primarily a CCR2 ligand, emerging evidence suggests possible CCR5 interaction, challenging conventional views of chemokine specificity. Natural CCL2 missense mutations provide valuable insights into receptor interaction mechanisms and their potential role in HIV infection modulation, offering new perspectives on viral entry inhibition strategies. Materials and methods. The wild-type complex was modeled using AlphaFold Server with rigorous validation. From UniProt database, we selected 41 CCL2 mutations within predicted CCR5 binding sites based on structural analysis. For each variant, we generated mutant protein structures and complex models using FoldX algorithm in YASARA environment. We calculated binding energies, complex stability, and interaction energy parameters, while conducting detailed analysis of atomic contacts and hydrogen bonding patterns. Functional impact of mutations was assessed using PolyPhen-2 algorithm. Results. Molecular modeling identified 35 CCL2 residues forming the comprehensive CCR5 interface. Five specific mutations (P78H, S57C, I28V, N29A, K79A) significantly enhanced CCR5 binding affinity, reducing interaction energy compared to wild type. P78H and S57C variants showed the strongest effects and were consistently predicted as “probably damaging”. K79A demonstrated substantially improved binding while maintaining reasonable interfacial contacts. Detailed structural analysis revealed these mutations optimize the binding interface through strategic reorganization of molecular interactions and improved complementarity. Discussion. Our findings demonstrate that specific natural CCL2 mutations can substantially enhance CCR5 binding affinity, revealing unexpected plasticity in chemokine-receptor recognition systems. The most impactful mutations suggest evolutionary mechanisms for modulating HIV entry pathways through natural genetic variation. These results provide structural insights into how sequence variations might influence viral pathogenesis through altered receptor specificity and binding kinetics. Conclusion. This computational study identifies key CCL2 mutations that significantly enhance CCR5 binding, expanding our understanding of chemokine system flexibility and evolutionary adaptation. The results support further experimental investigation of natural CCL2 variants as potential modulators of HIV infection and contribute to fundamental knowledge of virus-host interactions at molecular level.

  • Open Access

    Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico

    by Vladimir S. Davydenko, Alexander N. Shchemelev, Yulia V. Ostankova, Ekaterina V. Anufrieva, Areg A. Totolian

    The human immunodeficiency virus (HIV) remains a major global health challenge. A promising therapeutic strategy involves identifying human proteins capable of physically blocking viral entry by interacting with key components of the HIV attachment system. To address this challenge systematically, we developed a computational pipeline for prioritizing protein–protein interaction and applied it to identify host proteins interacting with the viral glycoprotein gp120 and cellular receptors (CD4, CCR5, CXCR4, CCR2). Our approach combined large-scale interaction modeling using AlphaFold 3 with a comprehensive comparative analysis framework. We screened a panel of 55 candidate human proteins selected through integrated bioinformatics analysis. The pipeline incorporated model confidence assessment, quantitative contact analysis, and normalization against reference interactions to generate a robust ranking of candidates. Key findings reveal several important patterns. Chemokine CCL27 uniquely demonstrated high binding potential to both CCR5 co-receptor and viral gp120, suggesting its potential for dual-blockade capability. Analysis of natural ligand interactions with chemokine receptors showed marked disparity: CC-chemokine family members exhibited significantly greater binding capacity for CCR5 and CCR2 receptors compared to CXC-family ligand interactions with CXCR4. This binding imbalance may potentially drive selective viral pressure and influence tropism evolution during disease progression. We also identified potential interactions between HIV entry components and neuropeptides including PNOC and NPY, as well as various membrane receptors beyond classical coreceptors. Furthermore, cluster analysis revealed clear separation between receptor-type and ligand-type interactors, supporting the biological plausibility of our predictions. While acknowledging limitations related to model refinement, this study provides a systematically ranked set of candidate targets for HIV therapeutic development. Beyond identifying specific HIV interaction candidates, this study establishes a generalizable computational pipeline for the prioritization of protein–protein interaction in pathogen-host systems, effectively bridging large-scale modeling.


  • Open Access

    Identification of human genes potentially involved in the pathogenesis of viral hepatitis C based on multi-network bioinformatics analysis

    by Ekaterina V. Anufrieva, Yulia V. Ostankova, Vladimir S. Davydenko, Alexandr N. Schemelev, Areg A. Totolian

    Aim. The aim of this study was to search for human genes potentially involved in the pathogenesis of hepatitis C by multi-network bioinformatics linkage analysis of proteins involved in the stages of hepatitis C virus (HСV) attachment and entry. Materials and methods. A number of web applications with complementary algorithms and databases were used to analyze genetic and protein-protein networks. The following genes were used as basic genes: CD81, CLDN1, LDLR, OCLN, SCARB1, the products of which are involved in interaction with viral glycoproteins E1 and E2 at the stage of HCV attachment and penetration into the cell. Data analysis was performed, including a two-stage scoring ranking of the identified candidate genes based on their interaction with basic genes and their presence in the results of network analysis of different web resources. Results. Candidate genes were initially identified using three web resources: HumanNet – 100 candidate genes, GeneMania – 20, STRING – 98. Based on the intersection of the three web resources, the total number of candidate genes associated with basic genes was 170. The total number of genes with a rank higher than 4 points was 35. Candidate genes were grouped into functional sets: cellular barriers and intercellular contacts (17 genes, 48.6%); lipid metabolism and lipoproteins (9 genes, 25.7%); immune response and interaction with the virus (5 genes, 14.3%); signaling pathways, proteolysis and cytoskeleton (4 genes, 11.4%). The following candidate genes potentially involved in the pathogenesis of HCV have been identified: APOA1, CLDN3, APOE, LIPC, LRPAP1, CSNK1E, APOB, CD19, CLDN6, CLDN9, ESAM, F11R, IFITM1, LDLRAP1, PCSK9, TJP1, CD9, CLDN11, CLDN17, CLDN2, CLDN5, IGSF8, MMP2, PDZK1, ADAM10, APOA2, C3, CLDN12, DAB1, GJB1, ITGB1, MYLIP, NEDD4L, PTGFRN. Conclusion. In the future, a detailed study of the functional features and polymorphic variants of the identified genes using bioinformatics and laboratory methods can significantly expand current understanding of the involvement of human genes in the development of HCV infection and discover new targets for the development of drugs and therapeutic strategies.


  • Open Access

    Identification of human genes interacting with HIV attachment receptors and potentially involved in disease pathogenesis based on multi-network bioinformatics analysis

    by V. S. Davydenko, Yu. V. Ostankova, A. N. Shchemelev, E. V. Anufrieva, V. V. Kushnareva, A. A. Totolian

    The aim of the study was to search for candidate genes interacting with HIV attachment receptors (CCR5, CXCR4, CCR2, CD4) and potentially involved in disease pathogenesis, based on complex in silico network algorithms.Materials and methods. A number of web applications were used to analyse genetic and protein-protein networks, the algorithms and databases of which are complementary. The CD4 receptor and chemokine co-receptor genes CCR5, CXCR4 and CCR2 were used as background/baseline genes in all cases, as their protein products play a key role in the process of virus attachment to the cell. The data were analysed, including a two-stage ranking of the identified candidate genes according to their interaction with background genes and their presence in the results of network analysis of different web resources.Results and discussion. According to the results, candidate genes were identified using three web resources: HumanNet — 451 candidate genes, GeneMania — 86, STRING — 61. Based on the results of crossing the three web resources, the total number of candidate genes associated with background genes was 511. The total number of genes with a rank above 4 points was 68. Of these, 31 genes (45.6%) encoding C-C/C-X-C family chemokine ligands, 12 genes (17.6%) encoding C-C/C-XC receptors, 8 genes (11.8%) encoding receptors of other types, and 17 genes (25%) encoding proteins of other types. The following receptors and proteins that are not members of the C-C/C/C-X-C families of the indicated groups have been identified: ARRB2, TLR2, ADRA1A, ARRB1, FPR1, FPR3, GNAI1, PF4, PIK3CG, PPIA, S1PR3, GNA11, GNAI2, GNG2, PTPRC, ADRA1B, ADRB1, AFP, CD164, DBN1, GNB1, ITCH, RNF113A, SLC1A1, USP14.Conclusion. Most of the identified candidate genes interacting with HIV attachment receptors and potentially involved in the pathogenesis of the disease were those encoding chemokine receptors and their C-C/C-X-C family ligands, the role of which in the progression of HIV infection is known or under active investigation. At the same time, genes whose products have never been considered as possible participants in the pathogenesis of the disease were identified, but the results suggest that they may play a role in the regulation of virus entry and/or in the modulation of the immune response of the organism. Further bioinformatic and experimental studies of the functions and polymorphic variants of these genes will help to improve the understanding of the genetic basis of HIV pathogenesis and identify new directions for therapeutic approaches.


  • Open Access

    Prevalence of Serological and Molecular-Biological HIV-Infection, HBV and HCV Markers among Medical Workers

    by E. V. Anufrieva, Yu. V. Ostankova, E. N. Serikova, A. N. Shchemelev, V. S. Davydenko, D. E. Reingardt, E. B. Zueva, Areg A. Totolian

    The aim of our work was to assess the occurrence of serological and molecular-biological markers of HIV, HBV and HCV among medical workers from St. Petersburg. Materials and methods. The study material included 171 blood plasma samples from medical workers from St. Petersburg. The ELISA method was used to qualitatively determine HIV antigen/antibodies (Ag/Ab), HBsAg, antibodies to HBs and HBcore proteins (anti-HBs IgG, anti-HBcore total), and anti-HCV IgG. HIV RNA, HCV RNA and HBV DNA were detected by PCR. For all identified HBV samples, sequencing and subsequent analysis of the nucleotide sequences of the Pre-S1/Pre-S2/S region were performed. Results and discussion. The surveyed group was ranked by age into the following subgroups: 21–35 years (28.07 %), 36–50 years (26.90 %), 51–65 years (31 %) and over 66 years (13.45 %). Serological markers of HBV were detected in 91 (53.22 %) subjects, HCV – in 2 (1.17 %). No markers of HIV were detected. At the same time, markers for HBV and HCV were found in 1 (0.58 %) person. HBV DNA was detected in 4 (2.34 %) medical workers; HCV RNA and HIV were not detected. Significant differences in the prevalence and distribution of the analyzed serological markers between age groups were determined. All HBV isolates belong to genotype D, subgenotypes D1 (50 %) and D2 (50 %). High variability of the Pre-S1/Pre-S2/S region of HBV in the examined group has been shown. The results obtained indicate a relatively low prevalence of HBV and HCV in the examined group. Monitoring of the prevalence of blood-borne infections among medical workers remains an urgent task, primarily in relation to HBV.


  • Open Access

    Prevalence of parenteral viral hepatitis B and C markers among migrants in the North-West Federal District

    by E. N. Serikova, Yu. V. Ostankova, E. V. Anufrieva, D. E. Reingardt, A. N. Schemelev, E. B. Zueva, A. R. Ivanova, A. V. Semenov, A. A. Totolian

    The aim of our study was to assess the prevalence of serological and molecular biological markers of parenteral viral hepatitis B and C among international migrants in the North-West Federal District (NWFD).Materials and methods. The study included 537 blood plasma samples obtained from foreign nationals from 46 countries who underwent medical examination to obtain a work permit in the Migration Department of the North-West Federal District. We assayed for the presence of serological (anti-HCV IgG, HBsAg, anti-HBs IgG, anti-HBs IgG) and molecular biological (HCV RNA, HBV DNA) markers.Results and discussion. More than 80% of the examined citizens belonged to 11 out of 46 represented countries. The analysis revealed 6.1% of persons with anti-HCV IgG antibodies and 2.6% with HBsAg. HCV RNA and HBV DNA were detected in 2.79% and 8.19%, respectively. Among HCV RNA-positive individuals, four (0.74%) were undetectable for anti-HCV. 6.15% of HBsAg-negative hepatitis B patients were detected. The contribution of migrants’ countries of origin to the frequencies of serological and molecular biological markers of hepatitis B and C identified in the surveyed group is discussed.Conclusion. The study of migration processes and associated flows of socially significant infections plays a key role in controlling the spread of infectious diseases on the territory of the Russian Federation, including the strengthening of the Russian Federation’s strategy for the elimination of viral hepatitis.